Funds holding CYCLERION THERAPEUTICS INC
ISIN US23255M2044 · United States
- Fund holders
- 8
- Of which ETFs
- 1 7 other funds
- Value held
- 145K $
- Share of capital
- 1.7 % of 4.7M shares on Aug 4, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 22,415 | 30.3K $ | 0.00 % | 0.48 % | as of Feb 28, 2026 ↗ |
| Fidelity Nasdaq Composite Index ETF Fidelity Commonwealth Trust | 20,830 | 28.1K $ | 0.00 % | 0.44 % | as of Feb 28, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 16,137 | 24.8K $ | 0.34 % | as of Mar 31, 2026 ↗ | |
| Fidelity Small Cap Growth Fund Fidelity Securities Fund | 9,900 | 32.8K $ | 0.00 % | 0.21 % | as of Apr 30, 2026 ↗ |
| Fidelity Small Cap Growth K6 Fund Fidelity Securities Fund | 4,982 | 16.5K $ | 0.00 % | 0.11 % | as of Apr 30, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 3,367 | 4.5K $ | 0.07 % | as of Feb 28, 2026 ↗ | |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 2,260 | 3.1K $ | 0.05 % | as of Feb 28, 2026 ↗ | |
| Fidelity Advisor Health Care Fund Fidelity Advisor Series VII | 1,500 | 5K $ | 0.00 % | 0.03 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| Fidelity Small Cap Growth Fund Fidelity Securities Fund | 0.00 % | as of Apr 30, 2026 ↗ |
| Fidelity Small Cap Growth K6 Fund Fidelity Securities Fund | 0.00 % | as of Apr 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index ETF Fidelity Commonwealth Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Advisor Health Care Fund Fidelity Advisor Series VII | 0.00 % | as of Apr 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 8 | +3 | 81,391 | +62.4 % |
| 2026Q1 | 5 | 0 | 50,103 | +0.1 % |
| 2025Q4 | 5 | 0 | 50,073 | -6.3 % |
| 2025Q3 | 5 | 0 | 53,441 | +0.6 % |
| 2025Q2 | 5 | 0 | 53,141 | +0.1 % |
| 2025Q1 | 5 | -5 | 53,076 | -59.0 % |
| 2024Q4 | 10 | 0 | 129,308 | +0.9 % |
| 2024Q3 | 10 | 0 | 128,111 | -0.2 % |
| 2024Q2 | 10 | 0 | 128,430 | -1.1 % |
| 2024Q1 | 10 | -2 | 129,850 | -12.7 % |
| 2023Q4 | 12 | 148,726 |
Institutional managers
15 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 84,550 | 129.8K $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 18,261 | 28K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 16,797 | 26K $ | as of Mar 31, 2026 |
| Kovack Advisors, Inc. | 10,000 | 15.5K $ | as of Mar 31, 2026 |
| FMR LLC | 4,740 | 7.3K $ | as of Mar 31, 2026 |
| UBS Group AG | 3,391 | 5.3K $ | as of Mar 31, 2026 |
| GROUP ONE TRADING LLC | 192 | 295 $ | as of Mar 31, 2026 |
| OSAIC HOLDINGS, INC. | 130 | 201 $ | as of Mar 31, 2026 |
| MAI Capital Management | 100 | 155 $ | as of Mar 31, 2026 |
| Activest Wealth Management | 100 | 155 $ | as of Mar 31, 2026 |
| CITIGROUP INC | 89 | 137 $ | as of Mar 31, 2026 |
| WHI TRUST Co LLC | 72 | 112 $ | as of Mar 31, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | 5 | 8 $ | as of Mar 31, 2026 |
| Caitong International Asset Management Co., Ltd | 4 | 6 $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1 | 2 $ | as of Mar 31, 2026 |
Declared shareholders of CYCLERION THERAPEUTICS INC
1 beneficial ownership filing. These stakes do not add up: an asset manager filing aggregates its own funds, already counted above.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| FMR LLC and 1 other | 15.00 % | 649,547 | as of Apr 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding CYCLERION THERAPEUTICS INC". https://titelia.com/en/stocks/cyclerion-therapeutics-inc-US23255M2044